Biocon Biologics gets DCGI approval for emergency use of CytoSorb
US FDA recently approved CytoSorb for emergency use in CoVID-19 patients
Full Article
Biocon Biologics gets DCGI approval for emergency use of CytoSorb
Hindu
0 shares
1 views
You might like
Related news coverage
Biocon gets DCGI nod for CytoSorb use in critical Covid-19 cases
Biocon said its subsidiary Biocon Biologics has received the Drugs Controller General of India’s (DCGI) approval for an..
IndiaTimes